[Prevention and treatment of bladder tumors recurrence with furtulon].
To inquire into the value of oral furtulon therapy for bladder tumors. 103 patients were randomized into four groups and have been undergoing a long term follow-ups. Recurrent rate of oral furtulon therapy for bladder tumors (8.8%) and instillation of mitomycin C for preventing the recurrence of bladder tumors (12.5%) as compared to recurrent rate of control group(40%), which was statistically significant(P < 0.01). Overall, 4 patients (33.3%) had an effective response with furtulon. Furtulon has more effective for treatment and prophylaxis of bladder tumors.